Your browser doesn't support javascript.
loading
Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function.
Hämäläinen, Kreetta; Hirvensalo, Päivi; Neuvonen, Mikko; Tornio, Aleksi; Backman, Janne T; Lehtonen, Marko; Niemi, Mikko.
Afiliación
  • Hämäläinen K; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
  • Hirvensalo P; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Neuvonen M; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
  • Tornio A; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Backman JT; Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.
  • Lehtonen M; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
  • Niemi M; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Clin Transl Sci ; 17(3): e13773, 2024 03.
Article en En | MEDLINE | ID: mdl-38515340
ABSTRACT
Our aim was to evaluate biomarkers for organic anion transporting polypeptide 1B1 (OATP1B1) function using a hypothesis-free metabolomics approach. We analyzed fasting plasma samples from 356 healthy volunteers using non-targeted metabolite profiling by liquid chromatography high-resolution mass spectrometry. Based on SLCO1B1 genotypes, we stratified the volunteers to poor, decreased, normal, increased, and highly increased OATP1B1 function groups. Linear regression analysis, and random forest (RF) and gradient boosted decision tree (GBDT) regressors were used to investigate associations of plasma metabolite features with OATP1B1 function. Of the 9152 molecular features found, 39 associated with OATP1B1 function either in the linear regression analysis (p < 10-5) or the RF or GBDT regressors (Gini impurity decrease > 0.01). Linear regression analysis showed the strongest associations with two features identified as glycodeoxycholate 3-O-glucuronide (GDCA-3G; p = 1.2 × 10-20 for negative and p = 1.7 × 10-19 for positive electrospray ionization) and one identified as glycochenodeoxycholate 3-O-glucuronide (GCDCA-3G; p = 2.7 × 10-16). In both the RF and GBDT models, the GCDCA-3G feature showed the strongest association with OATP1B1 function, with Gini impurity decreases of 0.40 and 0.17. In RF, this was followed by one GDCA-3G feature, an unidentified feature with a molecular weight of 809.3521, and the second GDCA-3G feature. In GBDT, the second and third strongest associations were observed with the GDCA-3G features. Of the other associated features, we identified with confidence two representing lysophosphatidylethanolamine 225. In addition, one feature was putatively identified as pregnanolone sulfate and one as pregnenolone sulfate. These results confirm GCDCA-3G and GDCA-3G as robust OATP1B1 biomarkers in human plasma.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glucurónidos / Transportadores de Anión Orgánico Límite: Humans Idioma: En Revista: Clin Transl Sci Año: 2024 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glucurónidos / Transportadores de Anión Orgánico Límite: Humans Idioma: En Revista: Clin Transl Sci Año: 2024 Tipo del documento: Article País de afiliación: Finlandia